Thereapeutic Recommendantion for Children With a Hodgkin Lymphoma
NCT05407480 · Status: RECRUITING · Type: OBSERVATIONAL · Enrollment: 250
Last updated 2026-03-02
Summary
The GFAOP propose a simple and reproducible staging according to clinical, biological and radiological data.
Develop standardized but different therapeutic recommendations based on the availability or lack of radiation therapy in the pilot unites who will adapt these recommendations.
Conditions
- Staging
- Therapeutic Recommendations
Interventions
- OTHER
-
Observational
Descriptive data will be collected to evaluation compliance with the protocol and to evaluate outcome
Sponsors & Collaborators
-
Gustave Roussy, Cancer Campus, Grand Paris
collaborator OTHER -
French Africa Pediatric Oncology Group
lead OTHER
Principal Investigators
-
FATEN Ben Ayed, Professeur · French Africa Pediatric Oncology Group
Eligibility
- Min Age
- 0 Months
- Max Age
- 18 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2022-11-15
- Primary Completion
- 2028-12-31
- Completion
- 2030-12-31
Countries
- France
Study Locations
More Related Trials
-
Treating Young Patients With Newly Diagnosed, Low Stage, Lymphocyte Predominant Hodgkin Disease
NCT00107198 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE2
-
CCCG-HD-2018 for Children and Adolescents With Newly Diagnosed Hodgkin Lymphoma
NCT04726501 ·Status: ACTIVE_NOT_RECRUITING ·Phase: PHASE4
-
Treatment for Classical Hodgkin Lymphoma in Children and Adolescents
NCT02797717 ·Status: RECRUITING ·Phase: NA
-
Capizzi Escalating Methotrexate Versus High Dose Methotrexate in Children With Newly Diagnosed T-cell Lymphoblastic Lymphoma (T-LBL)
NCT05681260 ·Status: RECRUITING ·Phase: PHASE3
-
Chemotherapy With Low-Dose Radiation for Pediatric Hodgkin Lymphoma
NCT00352027 ·Status: COMPLETED ·Phase: PHASE2
-
Combination Chemotherapy Followed by Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin's Lymphoma
NCT00302003 ·Status: COMPLETED ·Phase: PHASE3
-
Paclitaxel Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem Glioma
NCT00031577 ·Status: TERMINATED ·Phase: PHASE1
-
Safety Study of Tarceva in Children With Refractory and Relapsed Malignant Brain Tumors and Newly Diagnosed Brain Stem Glioma
NCT00418327 ·Status: COMPLETED ·Phase: PHASE1
-
A Prospective Multicenters Clinical Cohort Study of Stratified Treatment of Chinese Children With Systemic ALK(+) ALCL
NCT03971305 ·Status: UNKNOWN
-
Combination Chemotherapy and Radiation Therapy in Treating Young Patients With Newly Diagnosed Hodgkin Lymphoma
NCT01026220 ·Status: COMPLETED ·Phase: PHASE3
-
Treatment for Patients With Stage III or IV Non-Hodgkin Lymphoma
NCT00187122 ·Status: COMPLETED ·Phase: NA
-
Topotecan, G-CSF, and Radiation Therapy in Treating Young Patients With Newly Diagnosed Brain Stem Glioma
NCT00107471 ·Status: TERMINATED ·Phase: PHASE1/PHASE2
-
Rare Tumours in Children and Adolescents (STEP)
NCT05773651 ·Status: RECRUITING
-
Combination Chemotherapy and Radiation Therapy in Treating Children With Previously Untreated Stage II, Stage III, or Stage IV Hodgkin's Disease
NCT00004010 ·Status: COMPLETED ·Phase: PHASE2
-
Chemotherapy With or Without Additional Chemotherapy and/or Radiation Therapy in Treating Children With Newly Diagnosed Hodgkin's Disease
NCT00025259 ·Status: COMPLETED ·Phase: PHASE3
-
Autologous Hematopoietic Stem Cell Transplantation in Pediatric Relapsed or Refractory Hodgkin Lymphoma After Nivolumab Treatment
NCT06931613 ·Status: ENROLLING_BY_INVITATION ·Phase: PHASE2
-
Combination Chemotherapy With or Without Radiation Therapy and Peripheral Stem Cell Transplant in Treating Children With Hodgkin's Lymphoma
NCT00025064 ·Status: UNKNOWN ·Phase: PHASE2
-
Combination Chemotherapy Followed By Stem Cell Transplant in Treating Young Patients With Progressive or Relapsed Anaplastic Large Cell Lymphoma
NCT00317408 ·Status: UNKNOWN ·Phase: NA
-
Observation, Radiation Therapy, Combination Chemotherapy, and/or Surgery in Treating Young Patients With Soft Tissue Sarcoma
NCT00346164 ·Status: COMPLETED ·Phase: PHASE3
-
Clinical and Therapeutic Impact of Large Genomic Studies at Diagnosis in Pediatric Solid Cancers
NCT06171971 ·Status: RECRUITING
-
Therapy Optimization Trial for the Treatment of Relapsed or Refractory Brain Tumors in Children
NCT00749723 ·Status: COMPLETED ·Phase: PHASE2/PHASE3
-
B-cell Mature Non-Hodgkin's Lymphoma Treatment Protocol in Children and Adolescents 2021
NCT05518383 ·Status: RECRUITING ·Phase: PHASE4
-
Low-Dose Radiation and Combination Chemotherapy Following Surgery in Children With Newly Diagnosed Medulloblastoma
NCT00031590 ·Status: TERMINATED ·Phase: PHASE2
-
Observation or Radiation Therapy and/or Chemotherapy and Second Surgery in Treating Children Who Have Undergone Surgery for Ependymoma
NCT00027846 ·Status: COMPLETED ·Phase: PHASE2
-
Securing Access to Innovative Molecules in Oncology and Hematology for Children, Adolescents and Young Adults
NCT04477681 ·Status: RECRUITING